Predict your next investment

HEALTHCARE | Disease Diagnosis

See what CB Insights has to offer

Founded Year


About OvaGene Oncology

OvaGene Oncology is a molecular diagnostics that provides gene-based assays to assist physicians/gynecologic oncologists in the diagnosis, radiation, and chemotherapy, prognosis, and therapy selection of gynecologic cancers in women. It offers gene-based tumor profiling tests including pharmacogenetic analysis, next-gen sequencing and tumor drug response; ovarian, uterine/endometrial, and cervical cancer assays, including chemotherapy drug response profiles, targeted therapy response profiles, next-gen sequencing for targeted therapy, and pharmacogenetic assays.

OvaGene Oncology Headquarter Location

10 Pasteur Street Suite 150

Irvine, California, 92618,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.